Table 1 Clinicopathological parameters of cases (n = 135)
From: c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence
Parameter | Number (%) | |
|---|---|---|
Sex | Male | 67 (49.6 %) |
Female | 68 (50.4 %) | |
Grade | Well-differentiated | 31 (23 %) |
Moderately-differentiated | 85 (63 %) | |
Poorly-differentiated | 19 (14 %) | |
Age | <60 years | 72 (53.3 %) |
≥60 years | 63 (46.7 %) | |
Tumour location | Right colon | 38 (28.1 %) |
Left colon | 83 (61.5 %) | |
Rectum | 14 (10.4 %) | |
Tumour size | <5 cm | 56 (%41.5) |
≥5 cm | 79 (58.5 %) | |
Primary tumour | T1 | 3 (2.2 %) |
T2 | 14 (10.4 %) | |
T3 | 108 (80 %) | |
T4 | 10 (7.4 %) | |
Nodal metastasis | Positive | 63 (46.7 %) |
Negative | 68 (50.3 %) | |
Cannot be assessed | 4 (3 %) | |
Distant metastasis | Positive | 40 (29.6 %) |
Negative | 95 (70.4 %) | |
Lymphovascular invasion | Positive | 20 (14.8 %) |
Negative | 115 (85.2 %) | |
Margin status | Involved | 9 (6.7 %) |
Free | 126 (93.3 %) | |
Local disease recurrence | Recurrence | 48 (35.6 %) |
No recurrence | 87 (64.4 %) | |
Survival | Died of disease | 26 (19.3 %) |
Alive | 89 (65.9 %) | |
Not available | 20 (14.8 %) | |